As pregnant women are in a differential state of inflammation due to gestation, with relatively higher levels of IL-1β, IL-4, IL-5, and IL-10 (64), we hypothesized this could impact cytokine/chemokine levels during acute COVID-19. The gene discussed is IL1B; the disease is COVID-19.